About This Webinar
Mild Cognitive Impairment: An uncertain diagnosis or a diagnostic uncertainty?
A panel discussion sponsored by Biogen

There is significant heterogeneity in terms of the usefulness of a mild cognitive impairment (MCI) diagnosis, and although there is increasing scientific evidence around MCI being an appropriate and useful diagnosis, there is still some debate in the scientific community on this topic with clinical arguments on both sides.

The objective of this symposium is to provide a platform for scientific discussion on the topic and to cover the issues surrounding this subject so the audience can hear different perspectives and make an informed opinion on the topic.

This symposium has been developed and funded by Biogen

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.

One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, and is focused on potential therapies in neuromuscular, neurodegenerative, and ophthalmology disease areas.

Biogen also believes that biosimilars, and their associated cost-savings, are central to safeguarding future healthcare.

To learn more, please visit www.biogen.uk.com, www.biogen.ie
Presenters
  • 1591633374-ac3c65c763779384
    Chair: Professor Alistair Burns, CBE
    Professor of Old Age Psychiatry, University of Manchester
    Professor Alistair Burns is Professor of Old Age Psychiatry and Vice Dean for the Faculty of Medical and Human Sciences at The University of Manchester. He is an Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT) and is the National Clinical Director for Dementia and National Clinical Director for Mental Health in Older People at NHS England.

    He graduated in medicine from Glasgow University in 1980 and trained in psychiatry at the Maudsley Hospital and Institute of Psychiatry in London. He became the Foundation Chair of Old Age Psychiatry at the University of Manchester in 1992, where he has been Head of the Division of Psychiatry and Vice Dean in the Faculty of Medical and Human Sciences, with responsibility for liaison within the NHS. He set up the memory clinic in MMHSCT and helped establish the old age liaison psychiatry service in UHSMT. He is a past President of the International Psychogeriatric Association.

    He is Editor of the International Journal of Geriatric Psychiatry and is on the Editorial Boards of the British Journal of Psychiatry and International Psychogeriatrics. His research and clinical interests are in mental health problems of older people, particularly dementia and Alzheimer's disease. He has published over 300 papers and 25 books
  • 1591634361-d955e75902c2e627
    John O'Brien
    Professor of Old Age Psychiatry, Department of Psychiatry, University of Cambridge
    Professor John T O’Brien is Professor of Old Age Psychiatry in the Department of Psychiatry at the University of Cambridge and Honorary Consultant Old Age Psychiatrist within Cambridgeshire and Peterborough NHS Trust and Cambridge University Hospitals NHS Trust. He is also a National Institute for Health Research Emeritus Senior Investigator and a fellow of the UK Academy of Medical Sciences.

    His research interests include: the application of neuroimaging in old age psychiatry; dementia with Lewy bodies; the role of vascular factors in dementia and depression and clinical trials. He has published over 500 peer-reviewed papers on these topics and is a member of the National Institute for Health and Clinical Excellence (NICE), British Association of Psychopharmacology and the European Federation of Neurological Sciences (EFNS) Dementia Guideline groups. He is past President of the International College for Geriatric Psychoneuropharmacology (ICGP) and a recipient of the Royal College of Psychiatrists Lifetime Achievement award in Older People’s Mental Health.

    His other current roles include being the NIHR National Specialty Lead for Dementia and Treasurer of the International Vas-Cog Society.
  • 1625153553-2e8738bf9a39c8bb
    Professor Craig Ritchie
    Professor of the Psychiatry of Ageing, University of Edinburgh
    Prof Craig Ritchie is the Professor of Psychiatry of Ageing at the University of Edinburgh and Director of Brain Health Scotland.

    His academic interest is in the earliest stages of neurodegenerative disease and how they can be detected and managed to prevent dementia. He has run two international’s cohorts (EPAD and PREVENT) to generate the necessary data for this work. He has also been Chief Investigator on peer 30 clinical trials of investigational drugs and biological agents to treat Alzheimer’s disease.

    He has over 300 academic publications and led the first Massive Open Online Course (MOOC) titled: Understanding Brain Health: Preventing Dementia. He is also the Chair of the Scottish Dementia Research Consortium.
  • 1625153726-9555991c20cee068
    Dr Jeremy Isaacs
    Consultant Neurologist, St George's Hospital, London
    Dr Jeremy Isaacs is a consultant neurologist in the multi-disciplinary cognitive neurology service at St George’s Hospital which has a particular focus on supporting people living with young onset dementia.

    He was a member of the 2018 NICE dementia guideline committee. He is clinical director of the NHS London Dementia Clinical Network which oversees quality improvement in dementia care across the capital. He is the Neurosciences Clinical Academic Group director and an honorary senior lecturer at St George’s University of London and has research interests in Alzheimer’s and vascular dementias, delirium and functional cognitive disorder.
  • 1625153579-cfa45b0b0a01e4f2
    Dr Richard Perry
    Consultant Neurologist, Imperial College Healthcare NHS Trust, London
    Dr Perry is a consultant neurologist and honorary senior lecturer at Imperial College NHS Trust.

    Dr Perry gained his specialist clinical and research experience in cognition and memory disorders at the University of Cambridge Neurology Unit and the University of California, San Francisco. He runs memory clinics at Charing Cross Hospital and his area of special interest is in the early diagnosis and treatment of Alzheimer’s disease.

    Dr Perry conducts trials for investigational drugs in Alzheimer’s disease. His clinical neurological work also includes assessment and care of patients with traumatic brain injury. He has both a specialist and general clinical neurology practice.
Powered by BigMarker